Suppr超能文献

庆大霉素骨移植体的制备及感染性骨缺损治疗的实验研究

[Preparation of gentamicin-impregnated bone allograft and experimental study on treatment of infective bone defect].

作者信息

Li Baoxing, Zhang Yuming, Zhao Yaping

机构信息

Institute for Radiation Protection, Taiyuan Shanxi, PR China.

出版信息

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2006 Sep;20(9):920-4.

Abstract

OBJECTIVE

To study and prepare a new kind of bone graft, which has osteogenesis, local anti-infective function and low immunogenicity.

METHODS

Gentamicin-impregnated bone was prepared by means of ultrasonic and vacuum, the release of gentamicin in vivo was measured by inhibition bacteria. Ten healthy male adult sheep were made animal infection models of thigh bone or humerus defect of 6 mm x 6 mm x 20 mm at size, and the defect was inoculated into 1 ml 5 x 10(10) CFU/ml Staphylococcus aureus. The animals were randomly divided into the experimental group (n=5, the bone graft with gentamicin was implanted) and the control group (n=5, the bone graft without gentamicin). Macroscopic, WBC count, radiological, and histological investigations were carried out to evaluate the anti-infective and osteosis capability.

RESULTS

The concentrations of gentamicin were 46.1 microg/ml in bone allograft and 17.3 microg/ml in muscles after 1 day. The concentrations of gentamicin exceeding the minimum inhibitory concentration lasted for 14 days in vivo. WBC in the control group was higher than that in the experimental group. In the control group, 1 case died owing to septicemia 3 weeks after operation. The implanted bones were wrapped in pus 4 and 6 weeks, and the defects were filled with fibre tissue 8 and 10 weeks after operation. In the experimental group, 1 case was infected, the others had a good concrescence. The bone allografts began to integrate with adjacent bone after 4-8 weeks and integrate well after 12 weeks. The X-ray and histological observation showed that new bone formed and took the place of bone allograft.

CONCLUSION

The gentamicin-impregnated bone allograft was of a good sustained release feature in vivo, local anti-infection and osteogenesis. It might be an ideal bone grafting material for bone defects with infection.

摘要

目的

研究并制备一种具有成骨、局部抗感染功能且免疫原性低的新型骨移植材料。

方法

采用超声和真空法制备庆大霉素骨,通过抑菌法测定庆大霉素在体内的释放情况。选取10只健康成年雄性绵羊制作大小为6 mm×6 mm×20 mm的大腿骨或肱骨缺损动物感染模型,缺损处接种1 ml 5×10(10) CFU/ml金黄色葡萄球菌。将动物随机分为实验组(n=5,植入含庆大霉素的骨移植材料)和对照组(n=5,植入不含庆大霉素的骨移植材料)。进行宏观、白细胞计数、放射学及组织学检查以评估抗感染和成骨能力。

结果

术后1天,同种异体骨中庆大霉素浓度为46.1μg/ml,肌肉中为17.3μg/ml。庆大霉素浓度超过最低抑菌浓度在体内持续了14天。对照组白细胞高于实验组。对照组1例术后3周因败血症死亡。术后4周和6周植入骨被脓液包裹,术后8周和10周缺损处被纤维组织填充。实验组1例感染,其余愈合良好。同种异体骨在4 - 8周开始与相邻骨整合,12周后整合良好。X线和组织学观察显示有新骨形成并取代了同种异体骨。

结论

含庆大霉素的同种异体骨在体内具有良好的缓释特性、局部抗感染及成骨能力。它可能是感染性骨缺损理想的骨移植材料。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验